Recurrent glomerulonephritis after kidney transplantation

Area of Science:

• Nephrology
• Transplantation Immunology

Background:

• Glomerular diseases are primary causes of end-stage renal failure in 30-50% of kidney transplant recipients.
• Recurrence of glomerulonephritis in the allograft is a significant factor in late graft loss, yet risk factors remain poorly understood.
• Recurrent disease in the allograft typically mirrors the presentation of the original native kidney disease.

Purpose of the Study:

• To review common glomerulonephritides that recur post-kidney transplantation.
• To emphasize the impact of post-transplant immunosuppression on recurrence.
• To discuss emerging therapeutic strategies for recurrent glomerular disease in renal allografts.

Main Methods:

• Literature review of recurrent glomerulonephritis in kidney transplant recipients.
• Analysis of treatment efficacy for recurrent glomerular diseases.
• Evaluation of risk factors and predictive challenges for recurrence.

Main Results:

• Plasma exchange may benefit early focal and segmental glomerulosclerosis recurrence by reducing proteinuria.
• Standard immunosuppressive therapy is generally ineffective for preventing or treating recurrent glomerular disease.
• Supportive measures, including strict blood pressure control and renin-angiotensin system inhibition, help slow graft function decline.

Conclusions:

• Kidney transplantation for primary glomerulonephritis offers survival rates comparable to other causes of end-stage renal failure.
• Living related kidney transplantation is generally not contraindicated, despite recurrence risks, due to favorable outcomes and donor scarcity.
• Further research into prophylactic immunosuppression and novel treatments is crucial for managing recurrent glomerulonephritis post-transplant.